La cadena de opciones muestra datos clave de las opciones de acciones de Edesa Biotech a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Edesa Biotech..

Edesa Biotech (NASDAQ:EDSA) Bolsa, Cadena de Opciones

Edesa Biotech

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AMOD

DGLY

EDSA

El Índice de Precios al Productor en EE. UU. subió un 3,5% en enero, superando las previsiones. ¿Cómo reaccionaron los mercados?

Acciones de EE. UU. reaccionan al alza tras el aumento del PPI: ¿qué esperar ahora?

Edesa Biotech Inc

Press Releases

Edesa Biotech Announces Upcoming Conference Schedule

Financing

Edesa Biotech's Founder Makes Strategic Investment in the Company

Edesa Biotech Reports Fiscal Year 2024 Results

Management

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Edesa Biotech Announces Chief Financial Officer Transition

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Abpro Hldgs

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Ainos

BioAtla

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Curis

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Evaxion

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Geovax Labs

Imunon

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Longeveron

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Lisata Therapeutics

Moleculin Biotech

MetaVia

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

BiomX

Portage Biotech

Pelthos Therapeutics

SAB Biotherapeutics

Synlogic

TAO Synergies

HC Wainwright & Co.

Brookline Capital

Comments

Edesa Biotech

Edesa Biotech (EDSA) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL